Kyongbo Pharmaceutical (214390.KS) Earnings Analysis
Kyongbo Pharmaceutical (214390.KS) has no confirmed upcoming earnings date. Trailing P/E 478.83.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 214390.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 214390.KS. This page updates as the calendar is published.
214390.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-12-30 | -21.23331 KRW | n/a | n/a | n/a |
| 2025-05-15 | -29.0712 KRW | n/a | n/a | n/a |
| 2025-03-18 | 73.27 KRW | n/a | n/a | n/a |
| 2024-11-14 | 45.22 KRW | n/a | n/a | n/a |
| 2024-08-14 | 6.55 KRW | n/a | n/a | n/a |
214390.KS valuation and analyst view
| Trailing P/E | 478.83 |
|---|---|
| Trailing EPS | 10.909 KRW |
| Price / book | 0.84 |
| Dividend yield | 0.98% |
| Market cap | 119.30B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Kyongbo Pharmaceutical (214390.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 214390.KS. This page updates as the calendar is published.
Did 214390.KS beat earnings last quarter?
Consensus estimate data was not available for 214390.KS's 2025-12-30 report.
What is 214390.KS's current P/E ratio and EPS?
214390.KS trades at a trailing P/E of 478.83 on trailing EPS of 10.909446480110429 KRW.
What do analysts rate 214390.KS?
214390.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.